Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, TTK | 0.0367 | 0.8976 | 0.5 |
Onchocerca volvulus | Deterin homolog | 0.0062 | 0.13 | 0.0065 |
Leishmania major | cytochrome p450-like protein | 0.0014 | 0.0101 | 0.5 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.0367 | 0.8976 | 1 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0062 | 0.13 | 0.0065 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0014 | 0.0101 | 0.5 |
Echinococcus multilocularis | dual specificity serine:threonine tyrosine | 0.0367 | 0.8976 | 0.8823 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0367 | 0.8976 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0014 | 0.0101 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0101 | 0.0113 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.13 | 0.1448 |
Schistosoma mansoni | dual specificity serine/threonine tyrosine kinase | 0.0367 | 0.8976 | 1 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0062 | 0.13 | 0.135 |
Onchocerca volvulus | 0.0062 | 0.13 | 0.0065 | |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0101 | 0.0113 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0062 | 0.13 | 0.135 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0367 | 0.8976 | 0.5 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0062 | 0.13 | 0.0065 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0014 | 0.0101 | 0.0113 |
Brugia malayi | Protein kinase domain containing protein | 0.0367 | 0.8976 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0062 | 0.13 | 0.0065 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0014 | 0.0101 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1249 | 0.1392 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.13 | 0.1448 |
Trypanosoma brucei | cytochrome P450, putative | 0.0014 | 0.0101 | 0.5 |
Echinococcus granulosus | dual specificity serine:threonine tyrosine | 0.0367 | 0.8976 | 0.8823 |
Loa Loa (eye worm) | TTK protein kinase | 0.0367 | 0.8976 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.